CBU
Community Bank System, Inc.
CBU offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has a slight edge over CBU overall, supported by stronger modeled upside and stronger fundamentals.
CBU Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CBU's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CBU.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CBU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $64.49 | — |
| Cheap | 15x | $67.52 | +4.7% |
| Current | 15x | $64.49 | — |
| Fair | 19x | $82.32 | +28% |
| Expensive | 21x | $93.38 | +45% |
Historical ranges are pointers, not guarantees.
CBU has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
CBU Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CBU, with profitability holding steady.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CBU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.98 | +12% |
| Q3 2026 | $4.43 | +14% |
| Q2 2026 | $4.31 | +17% |
| Q1 2026 | $4.12 | +14% |
| Q4 2025 | $3.97 | +15% |
| Q3 2025 | $3.88 | +24% |
| Q2 2025 | $3.67 | +18% |
| Q1 2025 | $3.61 | +16% |
| Q4 2024 | $3.44 | +40% |
CBU has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
CBU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $231.6M | +11% |
| Q2 2026 | $219.8M | +9.6% |
| Q1 2026 | $215.2M | +9.1% |
| Q4 2025 | $217M | +11% |
| Q3 2025 | $208.1M | +10% |
| Q2 2025 | $200.5M | +9.1% |
| Q1 2025 | $197.3M | +11% |
| Q4 2024 | $196.3M | +11% |
CBU has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 35% | -0.3 points |
| Q2 2026 | 37% | +3.8 points |
| Q1 2026 | 35% | +2.1 points |
| Q4 2025 | 33% | +0.3 points |
| Q3 2025 | 35% | +5 points |
| Q2 2025 | 33% | -0.8 points |
| Q1 2025 | 33% | +2.6 points |
| Q4 2024 | 33% | +8.1 points |
CBU's operating margin was 35% last quarter, about level with the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over CBU on profitability, with a higher operating margin.
CBU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $106.4M | +28% |
| Q2 2026 | $41.4M | +14% |
| Q1 2026 | $60.3M | +16% |
| Q4 2025 | $61.6M | +5.2% |
| Q3 2025 | $83.4M | +61% |
| Q2 2025 | $36.4M | +7.7% |
| Q1 2025 | $52M | -33% |
| Q4 2024 | $58.5M | +46% |
CBU has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CBU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +17K shares |
| 1 year | 0% | -4K shares |
| 3 years | -1.5% | -806K shares |
| 5 years | -3% | -1.6M shares |
| Available history | +1.1% | +552K shares |
CBU has 53M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $15.8M |
| Q2 2026 | $564,000 |
| Q1 2026 | $15.5M |
| Q4 2025 | $44,000 |
| Q3 2025 | $11M |
| Q2 2025 | $42,000 |
| Q1 2025 | $48,000 |
| Q4 2024 | $47,000 |
CBU spent $32M buying back its own shares over the past year, up 186% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CBU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CBU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.8x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | 3.0x | Elevated |
CBU has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CBU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 65.5 | Neutral |
CBU's weekly RSI is 55 (neutral) and its Stochastic is 66 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CBU PE vs Financial Services Sector
| Metric | CBU | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 12% above |
| PE % | 7 | 63 | 56 pts below |
CBU is trading at 15x earnings, a 12% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over CBU on valuation relative to its sector.
CBU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.9 | 4.2% above |
| 20 week MA | $63.8 | 1.1% above |
| 50 week MA | $62.6 | 3% above |
| 100 week MA | $60.4 | 6.8% above |
| 200 week MA | $55.9 | 15% above |
CBU has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CBU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $70.6 | $62.6 | -11% |
| 2021 | $62.6 | $74.2 | +18% |
| 2022 | $74.2 | $62.3 | -16% |
| 2023 | $62.3 | $52.1 | -16% |
| 2024 | $52.1 | $62.3 | +20% |
| 2025 | $62.3 | $59.0 | -5.2% |
| 2026 YTD | $59.0 | $64.5 | +9.2% |
CBU has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.